Skip to content

Modifying psychologicAl Treatment to the CHaracteristics and needs of cancer survivors.

Putting the patient at the center (of care): personalized treatment for psychological symptoms and fatigue in patients with cancer.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22291
Enrollment
190
Registered
2019-01-24
Start date
2018-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychological symptoms, cancer-related fatigue, personalized treatment, ecological momentary assessment (EMA), cancer survivors. Psychische klachten, vermoeidheid bij patiënten met kanker, gepersonaliseerde behandeling, EMA-metingen, overlevenden na kanker.

Interventions

The control group will receive standard, non-personalized psychological treatment for either fatigue, depressive symptoms or anxiety symptoms. This treatment will consist of existing evidence-based tr
(b) treatment form
(c) focus and content of treatment
(d) treatment duration. In both groups, treatment will be provided by well-trained psychologists.

Sponsors

Amsterdam UMC, location AMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Be ≥ 18 years old - Be able to speak and read Dutch - Previously diagnosed with cancer - Be at least six months and maximum 5 years after end of primary treatment with curative intent. - Have no disease activity at time of inclusion in the study. - Report either severe fatigue (Checklist Individual Strength - Fatigue, cutoff ≥ 35 subscale fatigue severity) , severe fear of cancer recurrence (6-item Cancer Worry Scale, cutoff ≥ 10) of severe depressive symptoms (Beck Depression Inventory Primary Care, cutoff ≥ 4), from which they experience functional impairments (Work and Social Adjustment Scale (W&SAS), cutoff ≥ 10).

Exclusion criteria

Exclusion criteria: - Insufficient command of the Dutch language - Currently receiving psychological or psychiatric treatment - No informed consent

Design outcomes

Primary

MeasureTime frame
Patient functioning

Secondary

MeasureTime frame
- Symptom level o Fatigue o Depressive symptoms o Fear of cancer recurrence - Quality of life - Goal attainment - Number of therapy sessions - Therapist time per patient - Dropout rate

Contacts

Public ContactSusan Harnas

Amsterdam UMC

matchmp@amc.uva.nl+3120-5663622

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)